These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9388866)

  • 21. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD56 is Expressed in Uterine Smooth Muscle Tumors.
    Karpathiou G; Chauleur C; Papoudou-Bai A; Dagher S; Peoc'h M
    Int J Gynecol Pathol; 2021 Jul; 40(4):315-323. PubMed ID: 32897962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smooth muscle tumors of the uterus: a practical approach.
    Toledo G; Oliva E
    Arch Pathol Lab Med; 2008 Apr; 132(4):595-605. PubMed ID: 18384211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings.
    Tanaka YO; Nishida M; Tsunoda H; Okamoto Y; Yoshikawa H
    J Magn Reson Imaging; 2004 Dec; 20(6):998-1007. PubMed ID: 15558559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical pathology of uterine smooth muscle tumors--borderline lesions between leiomyomas and leiomyosarcomas].
    Fujii S
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):385-90. PubMed ID: 3361191
    [No Abstract]   [Full Text] [Related]  

  • 26. Uterine Leiomyosarcoma Associated With Leiomyoma With Bizarre Nuclei: Histology and Genomic Analysis of 2 Cases.
    Fischer JV; Mejia-Bautista M; Vadasz B; Yin P; Bulun S; Tanner EJ; Lu X; Wei JJ
    Int J Gynecol Pathol; 2022 Nov; 41(6):552-565. PubMed ID: 35093974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD147 expression in uterine smooth muscle tumors, and its potential role as a diagnostic and prognostic marker in patients with leiomyosarcoma.
    Ozler A; Evsen MS; Turgut A; Sak ME; Tunc SY; Agacayak E; Alabalik U; Basaranoglu S; Keles AN; Gul T
    J Exp Ther Oncol; 2014; 10(4):325-30. PubMed ID: 25509988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
    Fadare O; Liang SX
    Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined uterine smooth muscle tumour: a challenging case.
    Viola P; Colasante A
    Pathologica; 2012 Aug; 104(4):193-7. PubMed ID: 23316624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histopathological, clinical and prognostic aspects of smooth-muscle tumors of the uterus (cellular myoma, leiomyosarcoma, endometrial stromal sarcoma)].
    De Giacomo G; Palla G; Paparatti L; Villani L; Moneta E
    Minerva Ginecol; 1988 Feb; 40(2):73-81. PubMed ID: 3399122
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative ultrastuctural study of leiomyosarcoma, cellular leiomyoma, and leiomyoma of the uterus.
    Ferenczy A; Richart RM; Okagaki T
    Cancer; 1971 Oct; 28(4):1004-18. PubMed ID: 5111736
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
    Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
    Ip PP; Tse KY; Tam KF
    Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Uterine fibroid associated with smooth muscle tumor of uncertain malignant potential (STUMP): about a case].
    Saoud MK; Benchiba I; Mamouni N; Errarhay S; Bouchikhi C; Banani A
    Pan Afr Med J; 2018; 31():151. PubMed ID: 31086612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
    Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
    J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the pathology of smooth muscle tumours of the uterus.
    Wilkinson N; Rollason TP
    Histopathology; 2001 Oct; 39(4):331-41. PubMed ID: 11683931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine smooth muscle tumors of unknown malignant potential: A challenging question.
    Gadducci A; Zannoni GF
    Gynecol Oncol; 2019 Sep; 154(3):631-637. PubMed ID: 31326137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uterine epithelioid smooth muscle tumor of uncertain malignant potential.
    Gomez NF; Zhao J; Smith B
    Int J Gynecol Cancer; 2023 Aug; 33(8):1324-1325. PubMed ID: 37268311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.